Current and Future Global Burden of Early-Onset Pancreatic Cancer: A Population-Based Study
EOPC incidence and mortality are rising globally, with middle and low-middle SDI regions facing the most rapid increases and projected to carry the greatest burden by 2040. These findings emphasize the need for primary prevention, access to diagnostics, and equitable health care systems. Addressing modifiable risk factors, such as smoking and metabolic syndrome, will be critical in reducing the overall impact of EOPC.
Authors
- Marcos Belotto (ORCID: https://orcid.org/0000-0001-5630-5004)
- Thais Baccili Cury Megid (ORCID: https://orcid.org/0009-0004-2063-872X)
- Luís Felipe Leite (ORCID: https://orcid.org/0009-0006-8347-1212)
- Renata D’Alpino Peixoto (ORCID: https://orcid.org/0000-0003-0053-7951)
- Mariana Macambira Noronha (ORCID: https://orcid.org/0000-0003-0889-7425)
- Lucas Diniz da Conceição (ORCID: https://orcid.org/0009-0004-4397-5200)
Institutions
- BC Cancer Agency (CA)
- Universidade Federal Fluminense (BR)
- Universidade Federal do Ceará (BR)
- Dr. Georges-L.-Dumont University Hospital Centre (CA)
- Vitalité Health Network (CA)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1200/go-25-00016
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00